AbsciABSI +2.82%47 FCF Yield % is -4.98 as of Jun. 30, 2026. GuruFocus rates ABSI with a GF Score™ of 47/100 and a GF Value™ of $0.94 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,415 Biotechnology companies, Absci ranks better than 62.26% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Absci's Trailing 12-Month Free Cash Flow is $-98.51 Mil, and Market Cap is $1,976.90 Mil. Therefore, Absci's FCF Yield % for today is -4.98%.
The historical rank and industry rank for Absci's FCF Yield % or its related term are showing as below:
ABSI'
s FCF Yield % Range Over the Past 10 Years
Min: -78.63 Med: -20.57 Max: -2.05
Current: -4.98
During the past 7 years, the highest FCF Yield % of Absci was -2.05%. The lowest was -78.63%. And the median was -20.57%.
ABSI's FCF Yield % is ranked better than 62.26% of 1415
companies
in the Biotechnology industry
Industry Median: -9.49
vs ABSI: -4.98
Absci's FCF Margin % for the quarter that ended in Mar. 2026 was -12,249.77%.
Absci FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Absci FCF Yield % Related Terms
Absci FCF Yield % Historical Data
* Premium members only.
The historical data trend for Absci's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Absci's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Absci FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Absci's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Absci's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Absci (ABSI) has a FCF Yield % of -4.98 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Absci and its competitors. According to the industry distribution chart, Absci ranks #534 out of 1415 companies in the Biotechnology industry, placing it in the top 37.7%.
Is Absci's FCF Yield % too high?
Absci's current FCF Yield % is -4.98. Based on the distribution chart, Absci ranks #534 out of 1415 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Absci has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Absci's FCF Yield % compare to ANAB and RXRX?
According to the Biotechnology industry distribution chart, Absci ranks #534 out of 1415 companies for FCF Yield %. This puts Absci in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Absci and its competitors. Absci's current FCF Yield % is -4.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Absci stock overvalued right now?
Based on GuruFocus' analysis, Absci (ABSI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.94, compared to a current price of $11.67 — trading 1141.5% above its estimated fair value. The current FCF Yield % is -4.98. Absci's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Absci (ABSI), the current FCF Yield % is -4.98 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Absci (ABSI) Overvalued in 2026?
Based on GuruFocus' analysis, Absci stock appears to be overvalued.
The current stock price of $11.67 is trading 1141.5% above its estimated GF Value™ of $0.94.
GuruFocus considers Absci to be Significantly Overvalued.
Key valuation signals for ABSI:
FCF Yield %: -4.98
GF Value™: $0.94 vs. price of $11.67 (1141.5% above fair value)
No single metric tells the full story. See the ABSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
47GF Score
Get the complete analysis for ABSI
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABSI has been successfully added to your 
